Transcriptomics

Dataset Information

0

Gene expression profiling in endothelial precursor cells of patients protected from microvascular complications


ABSTRACT: In this study, we examined the impact of modulating the TGF-β/PAI-1 axis in CD34+ cells function from diabetic patients and controls. Using gene array studies, we found that diabetics, protected from microvascular complications despite suboptimal glycemic control, had reduced level of TGF- β1 and PAI-1 transcripts in their CD34+ cells compared to age, sex, duration and degree of glycemic control -matched diabetics with microvascular complications. Treatment with neutralizing antibody to TGF- β1 in murine hematopoietic stem cells (HSC) enhanced in vivo repopulation potential of these cells in bone marrow transplantation; reduced the time required for cell division of single cells, increased survival of the progenitor cells and reduced TGF-β1 expression. TGF- β1 phosphorodiamidate morpholino oligomers (PMO) treatment reduced PAI-1 mRNA expression in diabetic (p<0.01) and non-diabetic (p=0.05) CD34+ cells. Inhibition of PAI-1 promoted CD34+ cell proliferation and migration in vitro.Targetting TGFβ-1/PAI-1 system offers a promising therapeutic strategy for restoring vascular reparative function in diabetic CD34+ cells and hematopoietic stem cells, enhancing key functions needed for cell therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE43950 | GEO | 2013/02/01

SECONDARY ACCESSION(S): PRJNA188223

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-02-01 | E-GEOD-43950 | biostudies-arrayexpress
2012-08-23 | E-GEOD-40301 | biostudies-arrayexpress
2018-10-24 | GSE121701 | GEO
2018-10-24 | GSE121687 | GEO
2018-10-24 | GSE121700 | GEO
2018-10-24 | GSE121693 | GEO
2023-04-01 | GSE226758 | GEO
2012-08-23 | GSE40301 | GEO
2009-02-28 | E-GEOD-9892 | biostudies-arrayexpress
2018-05-22 | GSE107942 | GEO